We all know about the unprecedented events of operation warp speed. The gene sequence of the supposed “Covid 19 virus” was released from China and 42 days later a vaccine entered clinical trial. In the below interview, Dave Johnson from Moderna explains now Artificial Intelligence was used to get this done.
Are there any dangers in that? Artificial Intelligence is now rapidly moving into Big Pharma domains for drug development.
After the transcript, I posted a review article discussing the concerns of dual use of Artificial Intelligence powered drug discovery. Dual use means civilian and military weapons development. The article is shocking, to say the least. They just checked if instead of deveoping useful molecules for health, they could find toxic bioweapons, lethal for humans.
Here is the answer:
In less than 6 hours after starting on our in-house server, our model generated forty thousand molecules that scored within our desired threshold.
Who are these scientists and why did they check for this?
An international security conference explored how artificial intelligence (AI) technologies for drug discovery could be misused for de novo design of biochemical weapons. A thought experiment evolved into a computational proof.
The Swiss Federal Institute for NBC-Protection—Spiez Laboratory—is part of the ‘convergence’ conference series1 set up by the Swiss government to identify developments in chemistry, biology and enabling technologies, which may have implications for the Chemical and Biological Weapons Conventions. Meeting every two years, the conference brings together an international group of scientific and disarmament experts to explore the current state of the art in the chemical and biological fields and their trajectories, to think through potential security implications, and to consider how these implications can most effectively be managed internationally. The meeting convenes for three days of discussion on the possibilities of harm, should the intent be there, from cutting edge chemical and biological technologies. Our drug discovery company received an invitation to contribute a presentation on how AI technologies for drug discovery could be potentially misused.
